New Feature Coming Soon, Stay Tuned!
Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.
NASDAQ
Unprofitable
Unprofitable
0.04Â ( 1.88%)
Relative Strenght
41
Volume Buzz
-27%
Earning Acce
No
Dist 52w H.
43%